OncoTargets and Therapy
短名 | OTT |
Journal Impact | 2.68 |
国际分区 | ONCOLOGY(Q3) |
期刊索引 | SCI Q2中科院 4 区 |
ISSN | 1178-6930 |
h-index | 86 |
国内分区 | 医学(4区)医学生物工程与应用微生物(3区)医学肿瘤学(4区) |
ONCOTARGETS AND THERAPY 是一份国际同行评审期刊,专注于癌症研究的分子方面,即所有类型癌症的分子诊断和靶向分子或精准治疗。该杂志的特点是快速报道高质量的原创研究、基础科学、评论和评估、专家意见和评论,为癌症或癌症亚型提供新的见解。该期刊涵盖的具体主题包括:-新的治疗靶点和创新药物-提高效益和/或减少副作用的新治疗方案-早期临床试验提交 ONCOTARGETS AND THERAPY 时的进一步考虑:-包含体内动物模型数据的研究将被视为有利。 - 将不考虑组织微阵列分析,除非它们得到涉及多个细胞系的综合生物学研究的支持。 - 只有在通过综合体外数据和人体组织样本分析验证时,才会考虑生物标志物关联研究。 - 利用公开可用数据(例如 GWAS/TCGA/GEO 等)的研究应增加关于特定疾病或相关表型的知识体系,并且必须使用作者自己的数据通过在独立样本集中复制和功能跟踪进行验证-向上。 - 生物信息学研究必须使用作者自己的数据通过在独立样本集中复制和功能跟进来验证。 - 不考虑单核苷酸多态性 (SNP) 研究。
期刊主页投稿网址涉及主题 | 医学生物遗传学内科学化学癌症生物化学癌症研究病理基因肿瘤科免疫学外科细胞凋亡细胞培养细胞生物学细胞细胞生长数学下调和上调 |
出版信息 | 出版商: Dove Medical Press Ltd,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2009,原创研究文献占比: 63.71%,自引率:0.00%, Gold OA占比: 96.46% |
平均审稿周期 | 网友分享经验:较慢,6-12周 |
平均录用比例 | 网友分享经验:较易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Knockdown of TRIM37 Promotes Apoptosis and Suppresses Tumor Growth in Gastric Cancer by Inactivation of the ERK1/2 Pathway [Retraction]
2024-9-1
Familial Acute Promyelocytic Leukemia: A Case Report and Review of the Literature
2024-9-1
The Study of PIK3CA Hotspot Mutations and Co-Occurring with EGFR, KRAS, and TP53 Mutations in Non-Small Cell Lung Cancer
2024-9-1
LncRNA WT1-AS/mir-494-3P Regulates Cell Proliferation, Apoptosis, Migration and Invasion via PTEN/PI3K/AKT Signaling Pathway In Non-Small Cell Lung Cancer [Retraction]
2024-9-1
Synergistic Effect of Ubiquitin-Specific Protease 14 and Poly(ADP-Ribose) Glycohydrolase Co-Inhibition in BRCA1-Mutant, Poly(ADP-Ribose) Polymerase Inhibitor-Resistant Triple-Negative Breast Cancer Cells
2024-9-1
Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six-Case Series
2024-8-1
Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression [Retraction]
2024-8-1
Tumor-Homing Antibody-Cytokine Fusions for Cancer Therapy
2024-8-1
Combination of Sintilimab and Anlotinib for Metastatic Osteosarcoma: A Case Report
2024-8-1
Down-Regulation of ZEB1 by miR-199a-3p Overexpression Restrains Tumor Stem-Like Properties and Mitochondrial Function of Non-Small Cell Lung Cancer [Retraction]
2024-8-1
The Efficacy and Safety of Apatinib and Anlotinib in Advanced Non-Small Cell Lung Cancer
2024-8-1
MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP) [Retraction]
2024-8-1
TRIM11 Promotes Proliferation, Migration, Invasion and EMT of Gastric Cancer by Activating β-Catenin Signaling [Retraction]
2024-8-1
G-Protein-Signaling Modulator 2 Expression and Role in a CD133+ Pancreatic Cancer Stem Cell Subset [Retraction]
2024-8-1
TRIM31 Promotes Glioma Proliferation and Invasion Through Activating NF-κB Pathway [Retraction]
2024-8-1
Nrf2-Mediated Antioxidant Response and Drug Efflux Transporters Upregulation as Possible Mechanisms of Resistance in Photodynamic Therapy of Cancers
2024-8-1
Icariin Mitigates the Growth and Invasion Ability of Human Oral Squamous Cell Carcinoma via Inhibiting Toll-Like Receptor 4 and Phosphorylation of NF-κB P65 [Retraction]
2024-8-1
Function and Therapeutic Potential of Non-Coding RNA in Ameloblastoma
2024-8-1
RAB43 Promotes Gastric Cancer Cell Proliferation and Metastasis via Regulating the PI3K/AKT Signaling Pathway [Retraction]
2024-8-1
KRASG12C Inhibitors in Non-Small Cell Lung Cancer: A Review
2024-8-1
circHIPK3 Promotes Cell Proliferation and Migration of Gastric Cancer by Sponging miR-107 and Regulating BDNF Expression [Retraction]
2024-8-1
A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis
2024-8-1
Successful Recanalization and Neurological Restoration in Cancerous Embolic Cerebral Infarction via Endovascular Stent-Retriever Embolectomy
2024-7-1
Liquid-Based Cytology of Small Cell Carcinoma of the Cervix: A Multicenter Retrospective Study
2024-7-1
Long Noncoding RNA UCA1 Targets miR-582-5p and Contributes to the Progression and Drug Resistance of Bladder Cancer Cells Through ATG7-Mediated Autophagy Inhibition [Retraction]
2024-7-1
Pharmacological Inhibition of Necroptosis Promotes Human Breast Cancer Cell Proliferation and Metastasis [Retraction]
2024-7-1
LncRNA LINC01140 Inhibits Glioma Cell Migration and Invasion via Modulation of miR-199a-3p/ZHX1 Axis [Retraction]
2024-7-1
Mechanistic Insight into the Autophagic and Apoptotic Activity of Kaempferol on Liver Cancer Cells
2024-7-1
Hsp90 Inhibitor NMS-E973 Exerts the Anticancer Effect Against Glioblastoma via Induction of PUMA-Mediated Apoptosis [Retraction]
2024-7-1
Nephrotoxicity in Bispecific Antibodies Recipients: Focus on T-Cell-Engaging Bispecific Antibodies
2024-7-1
LINC01087 is Highly Expressed in Breast Cancer and Regulates the Malignant Behavior of Cancer Cells Through miR-335-5p/Rock1 [Retraction]
2024-7-1
LncRNA NORAD Promotes Proliferation and Inhibits Apoptosis of Gastric Cancer by Regulating miR-214/Akt/mTOR Axis [Retraction]
2024-7-1
Impact of Combined Chemotherapy and Targeted Therapy on Pancreatic Neuroendocrine Carcinoma with Liver Metastasis: A Single-Center Modified Nomogram Analysis
2024-6-1
Different Role of TRF1 and TRF2 Expression in Non-Small Cell Lung Cancers
2024-6-1
Downregulation of lncRNA ANRIL Suppresses Growth and Metastasis in Human Osteosarcoma Cells [Retraction]
2024-6-1
Unraveling the Mechanism of Curculiginis Rhizoma in Suppressing Cisplatin Resistance in Non-Small Cell Lung Cancer: An Experimental Study
2024-6-1
Long Noncoding RNA LINC00460 Promotes Hepatocellular Carcinoma Progression via Regulation of miR-342-3p/AGR2 Axis [Retraction]
2024-6-1
Combined Silencing of VEGF-A and Angiopoietin-2, a More Effective Way to Inhibit the Ishikawa Endometrial Cancer Cell Line [Retraction]
2024-6-1
Combined Dacomitinib and Selpercatinib Treatment for a Patient with EGFR-Mutant Non-Small Cell Lung Cancer and Acquired CCDC6-RET Fusion
2024-6-1
Downregulation of MMSET Impairs Breast Cancer Proliferation and Metastasis Through Inhibiting Wnt/β-Catenin Signaling [Retraction]
2024-6-1
Red Sea Sponge Callyspongia siphonella Extract Induced Growth Inhibition and Apoptosis in Breast MCF-7 and Hepatic HepG-2 Cancer Cell Lines in 2D and 3D Cell Cultures
2024-6-1
Prolonged Clinical Benefit with Futibatinib in a Patient with FGFR Inhibitor–Pretreated FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma: Case Report
2024-6-1
The Role and Mechanism of the Histone Methyltransferase G9a in Tumors: Update
2024-5-1
Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France
2024-5-1
MCM5 is a Novel Therapeutic Target for Glioblastoma
2024-5-1
Scalp Metastasis After Breast Cancer Surgery: A Case Report
2024-5-1
Evaluating the Therapeutic Potential of Durvalumab in Adults with Locally Advanced or Metastatic Biliary Tract Cancer: Evidence to Date
2024-5-1
miRNA-99b-5p Targets FZD8 to Inhibit Non-Small Cell Lung Cancer Proliferation, Migration and Invasion [Retraction]
2024-5-1
Identification and Validation of Nicotinamide Metabolism-Related Gene Signatures as a Novel Prognostic Model for Hepatocellular Carcinoma
2024-5-1
Synchronous Multiple Primary Malignant Adenocarcinoma of the Descending Colon and Fungating Bleeding Adenocarcinoma of the Terminal Ileum Presenting Massive Rectal Bleeding: A Trap for the Unwary
2024-5-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远